Provided by Tiger Trade Technology Pte. Ltd.

Travere Therapeutics, Inc.

67.52
+0.01000.01%
Volume:109.64K
Turnover:7.45M
Market Cap:6.36B
PE:-141.72
High:68.73
Open:67.76
Low:67.40
Close:67.51
52wk High:68.73
52wk Low:22.06
Shares:94.26M
Float Shares:92.77M
Volume Ratio:0.79
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4764
EPS(LYR):-0.2864
ROE:-236.35%
ROA:-3.73%
PB:259.54
PE(LYR):-235.79

Loading ...

Sep 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Major Issues Report

Form 8-K - Current report
Jul 09, 2026

Major Issues Report

Form 8-K - Current report
Jun 17, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses